Accès à distance ? S'identifier sur le proxy UCLouvain
Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis.
Primary tabs
| Document type | Article de périodique (Journal article) – Lettre à l'éditeur |
|---|---|
| Access type | Accès interdit |
| Publication date | 2008 |
| Language | Anglais |
| Journal information | "Blood" - Vol. 111, no. 11, p. 5413-5415 (2008) |
| Peer reviewed | yes |
| Publisher | American Society of Hematology ((United States) New York) |
| issn | 0006-4971 |
| e-issn | 1528-0020 |
| Publication status | Publié |
| Affiliation | UCL - (MGD) Service d'hématologie |
| MESH Subject | Adult ; Erdheim-Chester Disease - drug therapy, metabolism ; Female ; Humans ; Male ; Middle Aged ; Piperazines - therapeutic use ; Protein Kinase Inhibitors - therapeutic use ; Pyrimidines - therapeutic use ; Receptor, Platelet-Derived Growth Factor beta - metabolism |
| Links |
| Bibliographic reference | Haroche, Julien ; Amoura, Zahir ; Charlotte, Frédéric ; Salvatierra, Juan ; Wechsler, Bertrand ; et. al. Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis.. In: Blood, Vol. 111, no. 11, p. 5413-5415 (2008) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/110184 |